Doctor profile · Federal record

Dr. Mark Christiansen, MD

Endocrinology, Diabetes & Metabolism Physician · Walnut Creek, CA

  • NPI 1821108218
  • 20 yrs on file
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
2405 Shadelands Dr Ste 300
Walnut Creek, CA 945985906
(925) 939-8585
Additional location
5725 W Las Positas Blvd, #210
Pleasanton, CA 945884007
(925) 463-1400
fax (925) 251-9026
Mailing address
Po Box 31396
Walnut Creek, CA 945988396

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
June 23, 2021
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
California #G62892

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1821108218. Last verified May 11, 2026.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$479
Transactions
5
Manufacturers
3
Payer (manufacturer) Industry Txns Amount
Medtronic, INC. 3 $320.72
AstraZeneca Pharmaceuticals Lp 1 $108.00
Dexcom, INC. 1 $50.62

By nature of payment

Food and Beverage
$371
Travel and Lodging
$108

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
84
Patients
0
Total drug cost
$45,072
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 35 0 $866
Liothyronine Sodium Generic 20 0 $841
Novolog (Insulin Aspart) Brand 17 0 $21,589
Ozempic (Semaglutide) Brand 12 0 $21,776

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Christiansen's medical specialty?
Dr. Mark Christiansen practices Endocrinology, Diabetes & Metabolism Physician in Walnut Creek, CA.
Where does Dr. Mark Christiansen practice?
Dr. Mark Christiansen practices at 2405 Shadelands Dr Ste 300, Walnut Creek, CA 945985906. Office phone: 9259398585.
What is Dr. Mark Christiansen's NPI?
Dr. Mark Christiansen's National Provider Identifier (NPI) is 1821108218, issued by NPPES.